Neuronal Damage, Neurocognitive Losses and Quality of Life Following High-Dose Chemotherapy in Children with Brain Tumors |
Children’s Hospital Los Angeles / Mary Nelson |
Nurse Researcher Grants |
2009 |
California |
Modeling Pediatric Leukemia in Zebra Fish to Enable Discovery of New Anti- Leukemic Compounds |
University of California, San Diego / David Traver, MD |
Innovation Grants |
2010 |
California |
Identifying Novel Therapeutic Combinations with 131I-MIBG to Treat Relapsed and Refractory Neuroblastoma |
The Regents of the University of California San Francisco / William Clay Gustafson, M.D., Ph.D. |
Reach Grants |
2014 |
California |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Predicting Outcome for Patients with Metastatic Neuroblastoma by Analysis of Bone Marrow and Blood for a Neuroblastoma Gene Expression Signature |
Children’s Hospital Los Angeles / Robert Seeger |
Innovation Grants |
2010 |
California |
New Approaches to Neuroblastoma Therapy (NANT) Consortium
|
Children’s Hospital Los Angeles / Robert Seeger, MD |
Phase I/II Infrastructure Grants |
2006 |
California |
Enhancing Immunotherapy of Neuroblastoma |
The Regents of the University of California, San Diego / Alice Yu, MD/PhD & Mitchell Diccianni, PhD |
Innovation Grants |
2016 |
California |
Adoptive Immunotherapy of Tr1 Cells to Improve Outcome of Allo-HSCT Treatment for Pediatric AML |
Stanford University / Maria-Grazia Roncarolo, MD & Rosa Bachetta, MD |
Reach Grants |
2015 |
California |